AI News NQ Analysis

6550 Polaris Pharmaceuticals-KY (Private Placement Completion)

NQ Score 49/100
N1 Content Completeness 10

AI Summary (NQ-processed)

Polaris Pharmaceuticals-KY (6550) announced the completion of its 2nd private placement of common shares for the 114th fiscal year. The company issued 34.9 million shares at 18 TWD per share, raising 628.2 million TWD. Payment was completed on May 22, which is also the capital increase record date.

AI Analysis

Frequently Asked Questions

Q: What is the private placement price for Polaris Pharmaceuticals?
A: 18 TWD per share.